Laboratory Analytical Instruments
Standard Industrial Classification: SIC 3826
Industry Insider Sentiment Analysis
The Laboratory Analytical Instruments sector (SIC 3826) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-04-23 00:05 | 2021-04-20 | ILMN | ILLUMINA, INC. | FLATLEY JAY T | Director | SELL | $401.83 | 4,000 | $1,607,320 | 156,933 |
| 2021-04-20 00:02 | 2021-04-16 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | SELL | $192.61 | 7,500 | $1,444,543 | 428,491 |
| 2021-04-15 23:59 | 2021-04-15 | QTRX | Quanterix Corp | Duffy David C. | Officer | SELL | $62.14 | 1,667 | $103,587 | 36,618 |
| 2021-04-16 01:47 | 2021-04-13 | A | AGILENT TECHNOLOGIES, INC. | McMullen Michael R. | Director, Officer | SELL | $132.50 | 8,966 | $1,187,995 | 270,158 |
| 2021-04-14 01:03 | 2021-04-12 | AVTR | Avantor, Inc. | Ohri Devashish | Officer | OPT+S | $32.37 | 100,160 | $3,242,179 | 155,888 |
| 2021-04-14 01:03 | 2021-04-12 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | Officer | SELL | $31.80 | 27,075 | $860,999 | 216,594 |
| 2021-04-14 01:02 | 2021-04-12 | AVTR | Avantor, Inc. | Bramwell James | Officer | SELL | $32.00 | 2,505 | $80,160 | 118,136 |
| 2021-04-14 01:02 | 2021-04-12 | AVTR | Avantor, Inc. | Miller Justin | Officer | OPT+S | $33.17 | 102,895 | $3,412,914 | 118,679 |
| 2021-04-13 23:40 | 2021-04-12 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Officer | OPT+S | $185.89 | 17,000 | $3,160,052 | 34,608 |
| 2021-04-13 02:01 | 2021-04-08 | A | AGILENT TECHNOLOGIES, INC. | McMullen Michael R. | Director, Officer | SELL | $130.26 | 15,095 | $1,966,275 | 279,124 |
| 2021-04-09 23:02 | 2021-04-08 | QTRX | Quanterix Corp | HRUSOVSKY E KEVIN | Director, Officer | SELL | $65.54 | 5,000 | $327,703 | 980,568 |
| 2021-04-08 23:34 | 2021-04-06 | TXG | 10x Genomics, Inc. | Saxonov Serge | Director, Officer, 10% owner | OPT+S | $195.81 | 15,000 | $2,937,143 | 880,468 |
| 2021-04-07 23:41 | 2021-04-06 | ILMN | ILLUMINA, INC. | FLATLEY JAY T | Director | SELL | $423.44 | 4,000 | $1,693,740 | 160,933 |
| 2021-04-07 23:34 | 2021-04-05 | ILMN | ILLUMINA, INC. | TOUSI SUSAN H | Officer | SELL | $409.41 | 800 | $327,526 | 44,143 |
| 2021-04-06 00:46 | 2021-04-01 | QTRX | Quanterix Corp | Mattoon Dawn | Officer | SELL | $62.52 | 215 | $13,441 | 33,210 |
| 2021-04-06 00:46 | 2021-04-01 | QTRX | Quanterix Corp | Roskey Mark T. | Officer | SELL | $62.51 | 136 | $8,502 | 24,436 |
| 2021-04-05 23:07 | 2021-04-01 | QTRX | Quanterix Corp | Chaubal Amol | Officer | SELL | $62.52 | 165 | $10,316 | 30,400 |
| 2021-04-05 23:07 | 2021-04-01 | QTRX | Quanterix Corp | Fry John J | Officer | SELL | $62.52 | 201 | $12,566 | 34,832 |
| 2021-04-05 23:12 | 2021-04-01 | QTRX | Quanterix Corp | HRUSOVSKY E KEVIN | Director, Officer | SELL | $62.52 | 3,432 | $214,556 | 985,568 |
| 2021-04-03 00:21 | 2021-04-01 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Officer | OPT+S | $184.52 | 10,000 | $1,845,212 | 30,357 |
| 2021-04-03 00:19 | 2021-04-01 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | Director, Officer, 10% owner | OPT+S | $184.54 | 41,666 | $7,689,006 | 36,636 |
| 2021-04-03 00:22 | 2021-04-01 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | SELL | $184.53 | 7,500 | $1,383,969 | 435,991 |
| 2021-04-02 00:48 | 2021-03-31 | A | AGILENT TECHNOLOGIES, INC. | Raha Samraat S. | Officer | SELL | $127.50 | 1,000 | $127,500 | 53,936 |
| 2021-03-26 03:32 | 2021-03-23 | TXG | 10x Genomics, Inc. | Kosaraju Sridhar | Director | SELL | $174.63 | 1,500 | $261,939 | 16,500 |
| 2021-03-24 23:41 | 2021-03-22 | ILMN | ILLUMINA, INC. | Dadswell Charles | Officer | SELL | $416.24 | 314 | $130,699 | 6,832 |
| 2021-03-23 23:28 | 2021-03-22 | BRKR | BRUKER CORP | Friend Cynthia M | Director | OPT+S | $60.43 | 1,800 | $108,766 | 8,686 |
| 2021-03-19 23:03 | 2021-03-19 | QTRX | Quanterix Corp | Duffy David C. | Officer | SELL | $58.36 | 1,667 | $97,286 | 38,285 |
| 2021-03-19 04:09 | 2021-03-17 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | SELL | $169.36 | 7,500 | $1,270,181 | 443,491 |
| 2021-03-19 02:20 | 2021-03-16 | ILMN | ILLUMINA, INC. | FLATLEY JAY T | Director | SELL | $421.06 | 4,000 | $1,684,240 | 164,933 |
| 2021-03-16 23:53 | 2021-03-12 | TXG | 10x Genomics, Inc. | Saxonov Serge | Director, Officer, 10% owner | OPT+S | $157.04 | 15,000 | $2,355,569 | 880,468 |
| 2021-03-16 23:52 | 2021-03-12 | TXG | 10x Genomics, Inc. | Hindson Benjamin J. | Director, Officer, 10% owner | OPT+S | $156.98 | 41,666 | $6,540,904 | 36,636 |
| 2021-03-17 00:30 | 2021-03-16 | QTRX | Quanterix Corp | HRUSOVSKY E KEVIN | Director, Officer | SELL | $61.32 | 5,000 | $306,592 | 989,000 |
| 2021-03-16 23:51 | 2021-03-12 | TXG | 10x Genomics, Inc. | CRUTCHFIELD BRADFORD | Officer | OPT+S | $157.01 | 17,000 | $2,669,218 | 34,608 |
| 2021-03-17 01:51 | 2021-03-12 | HBIO | HARVARD BIOSCIENCE INC | Green James W | Director, Officer | SELL | $5.98 | 35,000 | $209,300 | 2,279,778 |
| 2021-03-11 03:24 | 2021-03-08 | TXG | 10x Genomics, Inc. | McAnear Justin J. | Officer | OPT+S | $147.30 | 10,000 | $1,472,954 | 20,774 |
| 2021-03-11 01:08 | 2021-03-09 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | Officer | SELL | $28.21 | 10,000 | $282,100 | 243,669 |
| 2021-03-11 00:09 | 2021-03-08 | QTRX | Quanterix Corp | HRUSOVSKY E KEVIN | Director, Officer | SELL | $66.21 | 5,000 | $331,028 | 994,000 |
| 2021-03-10 01:29 | 2021-03-05 | ILMN | ILLUMINA, INC. | TOUSI SUSAN H | Officer | SELL | $402.24 | 800 | $321,792 | 44,943 |
| 2021-03-08 18:26 | 2021-03-05 | WAT | WATERS CORP /DE/ | REED JOANN A | Director | OPT+S | $263.31 | 1,600 | $421,296 | 39,685 |
| 2021-03-05 01:04 | 2021-03-02 | ILMN | ILLUMINA, INC. | FLATLEY JAY T | Director | SELL | $444.61 | 4,000 | $1,778,440 | 168,933 |
| 2021-03-04 01:11 | 2021-03-02 | AVTR | Avantor, Inc. | Wondrasch Michael | Officer | SELL | $28.71 | 3,036 | $87,164 | 145,438 |
| 2021-03-04 00:08 | 2021-03-01 | QTRX | Quanterix Corp | Mattoon Dawn | Officer | SELL | $81.33 | 217 | $17,648 | 33,425 |
| 2021-03-04 00:08 | 2021-03-01 | QTRX | Quanterix Corp | Chaubal Amol | Officer | SELL | $81.33 | 166 | $13,500 | 30,565 |
| 2021-03-04 00:07 | 2021-03-01 | QTRX | Quanterix Corp | Roskey Mark T. | Officer | SELL | $81.33 | 137 | $11,142 | 24,572 |
| 2021-03-04 00:07 | 2021-03-01 | QTRX | Quanterix Corp | Fry John J | Officer | SELL | $81.33 | 202 | $16,428 | 35,033 |
| 2021-03-04 00:08 | 2021-03-01 | QTRX | Quanterix Corp | HRUSOVSKY E KEVIN | Director, Officer | SELL | $81.33 | 3,443 | $280,014 | 999,000 |
| 2021-03-04 01:06 | 2021-03-01 | TXG | 10x Genomics, Inc. | STUELPNAGEL JOHN R | Director | SELL | $183.19 | 7,500 | $1,373,888 | 450,991 |
| 2021-03-04 01:20 | 2021-03-01 | PRPO | Precipio, Inc. | DANIELI ILAN | Director, Officer | BUY | $2.46 | 1,025 | $2,522 | 21,462 |
| 2021-03-03 04:31 | 2021-02-26 | PACB | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Hunkapiller Michael | Director | OPT+S | $31.02 | 234,246 | $7,265,866 | 848,405 |
| 2021-02-27 02:34 | 2021-02-24 | AVTR | Avantor, Inc. | Brophy Gerard | Officer | SELL | $27.93 | 3,059 | $85,438 | 172,384 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Laboratory Analytical Instruments sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3826) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Laboratory Analytical Instruments
Every transaction in the Laboratory Analytical Instruments industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.